Sofie Johansson Alm

Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia

Kristian Juul-Dam, Hans Beier Ommen, Charlotte Guldborg Nyvold et al. · British Journal of Haematology · 2020 · 33 citations · Full text

Patient‐tailored analysis of minimal residual disease in acute myeloid leukemia using next‐generation sequencing

Erik Delsing Malmberg, Sara Ståhlman, Anna Rehammar et al. · European Journal Of Haematology · 2016 · 30 citations

Comparison of RNA‐ and DNA‐based methods for measurable residual disease analysis in <i>NPM1</i>‐mutated acute myeloid leukemia

Louise Pettersson, Sofie Johansson Alm, Alvar Almstedt et al. · International Journal of Laboratory Hematology · 2021 · 24 citations

Minimal residual disease assessed with deep sequencing of <i>NPM1</i> mutations predicts relapse after allogeneic stem cell transplant in AML

Erik Delsing Malmberg, Sofie Johansson Alm, Malin Nicklasson et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2018 · 21 citations · Full text

Pathology, Myeloid Neoplasia, Hematological Malignancy +19

Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22);<i><scp>ETV</scp>6–<scp>RUNX</scp>1</i>: concordant results using quantitation of fusion transcript and flow cytometry

Sofie Johansson Alm, Charlotte Engvall, Julia Asp et al. · International Journal of Laboratory Hematology · 2016 · 12 citations